Cytosorbents Corp — Director's Dealing 2015

May 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2015-04-24

Reporting Person: Capponi Vincent (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-24	Common Stock	M	4000	$.875	Acquired	20724	Direct
2015-04-24	Common Stock	S	4000	$7.50	Disposed	16724	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-24	Stock Option	$0.875	M	4000	Disposed	2018-06-25	Common Stock (4000)	Direct

Footnotes

F1: Stock option exercise and open market sale conducted pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This option has been adjusted to reflect the twenty-five-for-one (25:1) reverse split of the common stock of CytoSorbents Corporation that occurred on December 3, 2014.

F3: The number of shares of common stock held by the reporting person has been reduced to reflect the twenty-five-for-one (25:1) reverse split described above.

F4: This option vested and became exercisable as to 25% of the shares on each of June 25, 2008, June 25, 2009, June 25, 2010 and June 25, 2011.